TFR2 and metabolic syndrome: This disruption can impair the hepcidin-TFR2 interaction, compromise hepatic iron sensing, and lead to increased systemic iron accumulation alongside an insufficient hepcidin response [23,24], which in turn contributes to the development of the MetS.